Keryx Biopharmaceuticals (NASDAQ:KERX) Investor Files Lawsuit over Alleged Misleading Statements
An investor in shares of Keryx Biopharmaceuticals (NASDAQ:KERX) filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities by Keryx Biopharmaceuticals in connection certain allegedly false and misleading statements.
View full press release